Evaluation

Please rate this CME activity. *

	Very Poor	Poor	Neutral	Good	Excellent
Overall Evaluation	Overall Evaluation - Very Poor	Overall Evaluation - Poor	Overall Evaluation - Neutral	Overall Evaluation - Good	Overall Evaluation - Excellent
Content	Content - Very Poor	Content - Poor	Content - Neutral	Content - Good	Content - Excellent
Usefulness	Usefulness - Very Poor	Usefulness - Poor	Usefulness - Neutral	Usefulness - Good	Usefulness - Excellent
Quality	Quality - Very Poor	Quality - Poor	Quality - Neutral	Quality - Good	Quality - Excellent

Please rate the extent to which each of the following learning objectives were met. *

Please use the scale: 1=Strongly disagree, 2=Disagree, 3=Neutral, 4=Agree, 5= Strongly agree

	1	2	3	4	5
Review multiple sclerosis subtypes, and discuss their appropriate symptomology and progressive characteristics.	Review multiple sclerosis subtypes, and discuss their appropriate symptomology and progressive characteristics. - 1	Review multiple sclerosis subtypes, and discuss their appropriate symptomology and progressive characteristics. - 2	Review multiple sclerosis subtypes, and discuss their appropriate symptomology and progressive characteristics. - 3	Review multiple sclerosis subtypes, and discuss their appropriate symptomology and progressive characteristics. - 4	Review multiple sclerosis subtypes, and discuss their appropriate symptomology and progressive characteristics. - 5
Examine the mechanisms of action of emerging therapies for the treatment of multiple sclerosis to ensure accurate treatment selection and initiation.	Examine the mechanisms of action of emerging therapies for the treatment of multiple sclerosis to ensure accurate treatment selection and initiation. - 1	Examine the mechanisms of action of emerging therapies for the treatment of multiple sclerosis to ensure accurate treatment selection and initiation. - 2	Examine the mechanisms of action of emerging therapies for the treatment of multiple sclerosis to ensure accurate treatment selection and initiation. - 3	Examine the mechanisms of action of emerging therapies for the treatment of multiple sclerosis to ensure accurate treatment selection and initiation. - 4	Examine the mechanisms of action of emerging therapies for the treatment of multiple sclerosis to ensure accurate treatment selection and initiation. - 5
Implement individualized treatment plans to effectively address patient-specific disease activity to reduce symptoms and improve quality of life for patients with multiple sclerosis.	Implement individualized treatment plans to effectively address patient-specific disease activity to reduce symptoms and improve quality of life for patients with multiple sclerosis. - 1	Implement individualized treatment plans to effectively address patient-specific disease activity to reduce symptoms and improve quality of life for patients with multiple sclerosis. - 2	Implement individualized treatment plans to effectively address patient-specific disease activity to reduce symptoms and improve quality of life for patients with multiple sclerosis. - 3	Implement individualized treatment plans to effectively address patient-specific disease activity to reduce symptoms and improve quality of life for patients with multiple sclerosis. - 4	Implement individualized treatment plans to effectively address patient-specific disease activity to reduce symptoms and improve quality of life for patients with multiple sclerosis. - 5

How many patients with multiple sclerosis do you see each month? *

After participating in this activity, please rate your confidence in the following. *

Please use the scale: 1=NOT at all confident, 2=Somewhat confident, 3=Confident, 4=Very confident, 5=EXTREMELY confident

	1	2	3	4	5
Your ability to discuss the appropriate symptomology and progressive characteristics of different multiple sclerosis subtypes	Your ability to discuss the appropriate symptomology and progressive characteristics of different multiple sclerosis subtypes - 1	Your ability to discuss the appropriate symptomology and progressive characteristics of different multiple sclerosis subtypes - 2	Your ability to discuss the appropriate symptomology and progressive characteristics of different multiple sclerosis subtypes - 3	Your ability to discuss the appropriate symptomology and progressive characteristics of different multiple sclerosis subtypes - 4	Your ability to discuss the appropriate symptomology and progressive characteristics of different multiple sclerosis subtypes - 5
Your understanding of the mechanisms of action of emerging therapies to treat multiple sclerosis	Your understanding of the mechanisms of action of emerging therapies to treat multiple sclerosis - 1	Your understanding of the mechanisms of action of emerging therapies to treat multiple sclerosis - 2	Your understanding of the mechanisms of action of emerging therapies to treat multiple sclerosis - 3	Your understanding of the mechanisms of action of emerging therapies to treat multiple sclerosis - 4	Your understanding of the mechanisms of action of emerging therapies to treat multiple sclerosis - 5

As a result of participating in this activity, I will consider implementing individualized treatment plans to effectively address patient-specific disease activity in MS patients. *

Yes

No

Do you feel the activity was fair, balanced, and free of commercial bias? *

Yes

No

If No, please explain

What topics would you like to see in future CME activities?

Do you wish to be notified by email when new educational programs are offered by Elsevier?

Yes

No

Elsevier CME

Pre-Activity Questions

Course Video

Post-Activity Test

Evaluation

Credit

Certificate

Webform

Course navigation

You are here

Evaluation

Pre-Activity Questions

Course Video

Post-Activity Test

Evaluation

Credit

Certificate

Webform

Course navigation